Dong-A Pharmaceutical announced the launch of the deodorant “Muchiro” on Jan. 5.

As indoor activities are on the rise in the wake of the strengthening of social distancing guidelines designed to prevent the spread of the COVID-19 pandemic, concern about a pleasant and clear indoors is mounting.

The deodorant market is growing in a steady pace on the back of a rise in the elderly and companion animals.

Muchiro has been developed to latch onto these trends of the times. Muchiro is noted for eliminating substances causing bad odors, including unbearable ones, beyond the functions of the ordinary deodorants whose fragrance covers bad odors.

 
The latest deodorant is made of natural plant extracts such as phytoncide-rich cypress leaves and Japanese cedar leaves.
Muchiro can be purchased at Dong-A Pharmaceutical’s mall for the elderly (smartstore.naver.com/dongapharm).

A Dong-A Pharmaceutical said consumer demand for deodorant and anti-virus agents is on the rise due to the growing number of families with pets and other lifestyle changes.

The official expressed hope that Muchiro, an odorless deodorant, will be a boon to those who are suffering from bad odors.

An image of Benachio from Dong-A Pharm. (Photos: Dong-A Pharmaceutical)

Dong-A Pharmaceutical’s ‘Benachio’ Sales Top 10 Billion Won

The digestive solution “Benachio” saw sales surpassed 10 billion won in annually.

Benachio made its debut in 2009. It was in 2016 that annual sales of the digestive solution medicine topped 10 million bottles, solidifying its share in the digestive solution market. Benachio saw cumulative sales top 114 million bottles since its launch. If you lined up all those bottles, it would be long enough to make 17 round trips between Seoul and Busan.

Benachio is efficacious for treating indigestive symptoms such as overeating, an upset stomach and vomiting by spurring the movements of bowls.

The non-carbonated digestive medicine is noted for reducing its burden on the stomach.

In particular, the Benachio is effective for digesting fatty food and meats by strengthening the function of funnel, considered to spur the secretion of bile acid.

A four-week clinical experiment of patients suffering from functional indigestion, conducted in 2014 showed that the Benachio proved to be efficacious in improving indigestion.

Dong-A Pharmaceutical diversified the Benachio lineup to meet customers’ needs.

The pharmaceutical company came up with a 20mL version for women and the elderly who cannot drink large amounts of dosage at once at the time of the launch of the digestive.

In 2012, Dong-A Pharmaceutical added pill and 75mL versions designed to expand options for consumers.

The pharmaceutical company has ramped up diverse marketing activities, such as TV advertising, to raise its brand recognition.

In 2018, the Benachio was selected as the No. 1 solution digestive medicine being loved at pharmacies by pharmacists.

Choi Jung-woong, manager in charge of branding the Benachio, extended thanks for pharmacists and customers who have loved the Benachio.

Dong-A Pharmaceutical will strive to develop products tailored to meet consumers’ needs down the road and make it a brand specializing in digestion, he added.